A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
Peroxisome proliferator-activated receptor gamma (PPARγ) is a target for insulin sensitizing drugs. Here the authors combine NMR, X-ray crystallography and MD simulations and report a structural mechanism for eliciting PPARγ inverse agonism, where coactivator binding is inhibited and corepressor bin...
Enregistré dans:
Auteurs principaux: | Richard Brust, Jinsai Shang, Jakob Fuhrmann, Sarah A. Mosure, Jared Bass, Andrew Cano, Zahra Heidari, Ian M. Chrisman, Michelle D. Nemetchek, Anne-Laure Blayo, Patrick R. Griffin, Theodore M. Kamenecka, Travis S. Hughes, Douglas J. Kojetin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/83045b413545471dafc949ec4db32b64 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Defining a conformational ensemble that directs activation of PPARγ
par: Ian M. Chrisman, et autres
Publié: (2018) -
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
par: Zahra Heidari, et autres
Publié: (2019) -
A molecular switch regulating transcriptional repression and activation of PPARγ
par: Jinsai Shang, et autres
Publié: (2020) -
Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
par: Matteo Zanardelli, et autres
Publié: (2014) -
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
par: Li-Song Zhang, et autres
Publié: (2012)